, , , , , 0
Thanks! You've already liked this
,

Featured Interview: CEO Jeffrey Bacha of DelMar Pharmaceuticals Inc. (NASDAQ: DMPI)

CEO Jeffrey Bacha of DelMar Pharmaceuticals Inc., discusses finding new drug therapies and current clinical trials.

   CEO Jeffrey Bacha of DelMar Pharmaceuticals Inc.(NASDAQ: DMPI) returns to Stock Day to discuss finding new drug therapies and current clinical trials.

 

The CEOs interviewed on the Stock Day Podcast did not incur any charges for their time with Uptick Newswire CEO Everett Jolly. Contact us at (602) 441-3474 if you would like further information. 

Source: Uptick Newswire

Leave a Reply

Sign-Up for the UPTICK Newswire Newsletter and receive small-cap stock investor news and research.

SIGN UP FOR THE EMAIL NEWSLETTER

By entering your email address you agree to our terms of service.

Available RSS Feeds:
All Posts
Top Stories
Interviews
Stock of the Day
Uptick Newswire - 10000 N. 31st Ave. C-307 Phoenix, AZ 85051 (602) 441-3474
Copyright © 2018 Uptick Newswire, LLC.